Roger D. Dansey - Apr 17, 2023 Form 4 Insider Report for Seagen Inc. (SGEN)

Signature
By: /s/ Jennifer Prosba For: Roger D. Dansey
Stock symbol
SGEN
Transactions as of
Apr 17, 2023
Transactions value $
-$1,333,088
Form type
4
Date filed
4/19/2023, 06:14 PM
Previous filing
Apr 12, 2023
Next filing
Apr 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGEN Common Stock Options Exercise $726K +10K +10.06% $72.64 109K Apr 17, 2023 Direct F1
transaction SGEN Common Stock Sale -$2.06M -10K -9.14% $205.95 99.4K Apr 17, 2023 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SGEN Non-Qualified Stock Option (right to buy) Options Exercise $0 -10K -35.61% $0.00 18.1K Apr 17, 2023 Common Stock 10K $72.64 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
F2 The sales reported in this Form 4 were effected pursuant to a written plan adopted on September 9, 2022 that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
F3 Reflects sales of common stock executed in multiple transactions at prices ranging from $205.66 to $206.35. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F4 Options vested at a rate of 25% on 8/30/2020. The remainder shall vest monthly until all the options are vested on 8/30/23.